Home › Funds › Stonepine Capital Management, LLC › MNKD
Stonepine Capital Management, LLC position in MNKD
MANNKIND CORP · Health Care
Stonepine Capital Management, LLC reported holding 250,000 shares of MNKD (MANNKIND CORP) in its Q2 2026 13F filing — a position valued at US$750K, representing 0.50% of its reported portfolio and ranking #50 among its reported holdings. Stonepine Capital Management, LLC has disclosed MNKD holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's MNKD position evolved
Stonepine Capital Management, LLC first disclosed a stake in MNKD in Q3 2025 at 157,569 shares (US$846K). Across 4 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$750K — an increase of 233,700 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2025 (shares fell 57% over the following quarter), a 81% trim in Q1 2026 (shares rose 74% over the following quarter), a 1434% increase in Q2 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 157.57K | $846.15K | New |
| Q4 2025 | 86.36K | $489.66K | Reduce |
| Q1 2026 | 16.30K | $39.94K | Reduce |
| Q2 2026 | 250.00K | $750.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MNKD and 13F data
MNKD (MANNKIND CORP) is a Health Care company. 27 other funds we track also report a position in MNKD — the largest reported positions include Rubric Capital Management LP (US$76.7M), Frazier Life Sciences Management, L.P. (US$28.1M), Deep Track Capital, LP (US$25.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MNKD
- Rubric Capital Management LP 18.00M sh · $76.68M · Q2 2026
- Frazier Life Sciences Management, L.P. 6.60M sh · $28.12M · Q2 2026
- Deep Track Capital, LP 6.00M sh · $25.56M · Q2 2026
- TSP Capital Management Group, LLC 4.18M sh · $16.30M · Q3 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held MNKD?
Stonepine Capital Management, LLC has disclosed MNKD holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Stonepine Capital Management, LLC's current position in MNKD?
As of Q2 2026, Stonepine Capital Management, LLC holds 250.00K shares of MNKD (MANNKIND CORP), valued at $750.00K, representing 0.50% of its reported portfolio and ranking #50.
Has Stonepine Capital Management, LLC been buying or selling MNKD?
In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC increased its position in MNKD.
Which other funds hold MNKD?
Other major institutional holders of MNKD include Rubric Capital Management LP, Frazier Life Sciences Management, L.P., Deep Track Capital, LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.